Methionine aminopeptidase type 3
AssigneePharmacia Corporation
InventorsRajeev Aurora, Stanton B. Dotson
Life of this patent
Estimating the term…
Abstract
The present invention relates to a human cDNA encoding a methionine aminopeptidase type-3 (MetAP-3) protein. The invention also relates to nucleic acid molecules associated with or derived from this cDNA including complements, homologues and fragments thereof, and methods of using these nucleic acid molecules, to generate, for example, polypeptides and fragments thereof. The invention also provides methods of using the nucleic acids, for example, to produce a protein and fragments thereof and to screen for compounds or compositions that preferentially or specifically effect the activity of a MetAP-3 protein.
Claims7
A purified nucleic acid encoding a protein having a methionine aminopeptidase (MetAP) type 3 (MetAP-3) activity selected from the group consisting of:
- (A) a nucleic acid comprising SEQ ID NO:
- 7, or its full complement, or a fragment thereof having a length of 300 to 1200 nucleotides;
- (B) a nucleic acid that specifically hybridizes under high stringency conditions to a nucleic acid of (A);
- (C) a nucleic acid encoding a protein having a sequence of SEQ ID NO:
- 8, or an enzymatically-active fragment of SEQ ID NO:
- 8 having a length greater than 100 contiguous amino acids;
- (D) a nucleic acid that specifically hybridizes under high stringency conditions to a nucleic of (C);
- and
- (E) A nucleic acid fragment of SEQ ID NO:
- 7, wherein said fragment is 300 to 1200 contiguous nucleotides in length and encodes a protein having MetAP3 activity.
A purified MetAP-3 nucleic acid, which comprises a sequence that encodes a protein having MetAP3 activity and is identical to at least 300 contiguous nucleotides of SEQ ID NO:
- 7, or its full complement.
A method of producing a protein possessing MetAP-3 activity, comprising introducing a nucleic acid into a cell, the nucleic acid operably-linked to a promoter comprising a nucleic acid selected from the group consisting of:
- (A) a nucleic acid encoding a protein having a sequence of SEQ ID NO:
- 8 or a fragment of SEQ ID NO:
- 8 having a length of greater than 100 amino acids;
- and
- (B) a nucleic acid that specifically hybridizes under high stringency conditions to the full complement of (A).
Dependencies are inferred from the claim text.